Tandem Diabetes Care, Inc. Forecast, price target & analysts
Tandem Diabetes Care, Inc. Target price 2026 - Analyst rating & recommendation
Tandem Diabetes Care, Inc. Classifications & Recommendation
Tandem Diabetes Care, Inc. Price Target
| Target Price | $27.54 |
| Price | $16.50 |
| Potential |
66.91%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target Tandem Diabetes Care, Inc. 2027 .
The average Tandem Diabetes Care, Inc. target price is $27.54.
This is
66.91%
register free of charge
$52.50
218.18%
register free of charge
$18.18
10.18%
register free of charge
|
|
| A rating was issued by 29 analysts: 18 Analysts recommend Tandem Diabetes Care, Inc. to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Tandem Diabetes Care, Inc. stock has an average upside potential 2027 of
66.91%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.01 | 1.09 |
| 7.93% | 7.81% | |
| EBITDA Margin | -5.96% | 5.11% |
| 32.11% | 185.76% | |
| Net Margin | -20.17% | -4.44% |
| 97.51% | 77.99% |
26 Analysts have issued a sales forecast Tandem Diabetes Care, Inc. 2026 . The average Tandem Diabetes Care, Inc. sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Tandem Diabetes Care, Inc. EBITDA forecast 2026. The average Tandem Diabetes Care, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
26 Tandem Diabetes Care, Inc. Analysts have issued a net profit forecast 2026. The average Tandem Diabetes Care, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.04 | -0.70 |
| 106.80% | 76.97% | |
| P/E | negative | |
| EV/Sales | 1.19 |
26 Analysts have issued a Tandem Diabetes Care, Inc. forecast for earnings per share. The average Tandem Diabetes Care, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Tandem Diabetes Care, Inc....
Current Tandem Diabetes Care, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Locked
➜
Locked
|
Locked | Sep 30 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Sep 24 2026 |
| William Blair |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 15 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Jun 23 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citigroup:
Locked
➜
Locked
|
Sep 30 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Sep 24 2026 |
|
Locked
William Blair:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 15 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Jun 23 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
